Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
180 studies found for:    "Gastrointestinal Stromal Tumors"
Show Display Options
RSS Create an RSS feed from your search for:
"Gastrointestinal Stromal Tumors"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
Conditions: Gastrointestinal Stromal Tumors;   KIT +;   Resected Gastrointestinal Stromal Tumors;   Non-metastatic;   High Risk of Recurrence
Intervention: Drug: Imatinib maintenance
2 Completed Gastrointestinal Stromal Tumors (GIST) Registry
Condition: Gastrointestinal Stromal Tumors
Intervention: Other: GIST Registry
3 Completed Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
Condition: Gastrointestinal Stromal Tumors
Intervention:
4 Unknown  Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001
Condition: Gastrointestinal Stromal Tumor
Interventions: Genetic: mutation analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis
5 Active, not recruiting Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: dasatinib
6 Terminated Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Drug: sunitinib malate;   Other: pharmacological study
7 Completed S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: temozolomide
8 Recruiting Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: conventional surgery
9 Completed Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Nilotinib
10 Unknown  Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
Conditions: Gastrointestinal Stromal Tumor;   Metastatic Cancer
Intervention: Procedure: therapeutic conventional surgery
11 Completed Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: Nilotinib
12 Completed Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Glivec
13 Unknown  Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
Conditions: Gastrointestinal Stromal Tumor;   Metastatic Cancer
Intervention: Drug: imatinib mesylate
14 Completed Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: AMN107, STI571
15 Terminated
Has Results
Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients
Conditions: Gastrointestinal Stromal Tumors,;   Cancer,;   Solid Tumors
Interventions: Drug: Peginterferon-alpha 2b (PegIFNa2b);;   Drug: Imatinib
16 Completed Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Imatinib Mesylate
17 Completed Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
18 Active, not recruiting Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: imatinib mesylate
19 Terminated Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: therapeutic conventional surgery
20 Active, not recruiting Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: adjuvant therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years